#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12180	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2098	574.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1414	1414	C	711	C	697	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	0	.	n	.	0	T695C	SNP	695	695	T	997	997	C	718	C,T	689,16	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	0	.	n	.	0	G856C	SNP	856	856	G	1158	1158	C	761	C,G,T	699,43,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1639	1639	A	726	A,G	684,27	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2273	2273	C	661	C	640	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	0	.	n	.	0	C2696T	SNP	2696	2696	C	2998	2998	T	666	T,C	466,191	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2347	2347	A	667	A	655	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22486	23S	2890	2890	99.83	23S.l15.c30.ctg.1	3496	639.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2899	2899	C	664	C	652	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	1442	blaTEM	861	861	99.88	blaTEM.l15.c17.ctg.1	1393	101.9	0	.	p	.	0	M180T	NONSYN	538	540	ATG	800	802	ACG	145;145;142	A,C;C;G	141,1;143;137	.	Betalactam resistance
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1548	folP	852	852	99.88	folP.l6.c4.ctg.1	1451	105.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	698	700	AAA	128;131;133	A,G;A;A,G	121,5;127;128,1	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1548	folP	852	852	99.88	folP.l6.c4.ctg.1	1451	105.7	1	SNP	p	R228S	1	.	.	682	684	AGC	929	931	AGC	161;162;162	A;G;C	156;159;161	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4494	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3486	128.4	1	SNP	p	S91F	0	.	.	271	273	TCC	680	682	TCC	149;150;150	T;C,T;C	145;139,9;147	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4494	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3486	128.4	1	SNP	p	D95G	0	.	.	283	285	GAC	692	694	GAC	150;149;150	G;A,G,C;C	146;135,8,1;144	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4494	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3486	128.4	1	SNP	p	D95N	0	.	.	283	285	GAC	692	694	GAC	150;149;150	G;A,G,C;C	146;135,8,1;144	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1450	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1422	101.7	1	SNP	p	G45D	1	.	.	133	135	GAC	544	546	GAC	163;165;161	G;A,G;C	158;154,6;156	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	712	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	976	72.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4110	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2806	145.3	1	SNP	p	D86N	0	.	.	256	258	GAC	520	522	GAC	158;159;160	G;A;C,A	157;156;157,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4110	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2806	145.3	1	SNP	p	S88P	0	.	.	262	264	TCC	526	528	TCC	168;173;171	T;C;C	167;169;169	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3380	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2519	132.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1513	1515	GGC	165;165;163	G;G;C	162;163;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1242	1244	GCA	185;186;185	G,A;C;A,C	177,1;173;177,2	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1245	1247	ATC	188;187;190	A;T;C,G	181;180;178,2	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1257	1259	GTG	185;186;187	G,A;T,C;G,C	180,1;177,2;182,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1257	1259	GTG	185;186;187	G,A;T,C;G,C	180,1;177,2;182,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1761	1763	ACC	136;134;135	A;C;C	127;130;129	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1815	1817	GCG	135;134;137	G;C,G;G	128;119,1;130	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1815	1817	GCG	135;134;137	G;C,G;G	128;119,1;130	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1938	1940	GGC	111;108;106	G;G;C,T	109;106;101,3	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1947	1949	GGC	104;102;102	G,A;G;C	98,2;99;98	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3198	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2300	137.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1965	1967	CTG	92;93;90	C,G;T,C,G;G	78,5;73,6,2;75	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4762	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3024	156.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1581	1583	CCG	173;173;173	C;C,T;G,C	158;162,2;161,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1988	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1675	116.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	315	317	GGC	115;114;113	G,A;G;C	107,2;110;110	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1988	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1675	116.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	497	497	C	125	C	117	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	101	103	TTA	47;50;50	T,G;T;A	46,1;50;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	146	148	CAT	42;40;39	C,G;A;T	40,1;38;38	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	149	151	AGT	39;39;39	A;G;T	38;38;37	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	158	160	TAC	39;39;39	T,C;A;C	37,1;37;38	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	248	250	GAA	18;18;18	G;A;A	18;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	260	262	GCA	17;17;16	G;C;A	17;17;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	269	271	ATC	17;17;18	A;T;C	16;15;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	275	277	TCG	18;18;19	T;C;G	15;18;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	281	283	GCC	16;16;16	G;C;C	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	284	286	AGC	16;16;16	A;G;C	16;14;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	287	289	GCC	16;16;18	G;C;C	13;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	278	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	327	30.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	293	295	GTT	16;17;16	G;T;T	15;17;16	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2398	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1574	150.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	904	904	T	203	T,C	193,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2398	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1574	150.9	1	SNP	p	G120K	0	.	.	358	360	GGT	631	633	GGT	173;171;172	G,A;G,A;T,C,G	158,2;163,2;155,3,3	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2398	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1574	150.9	1	SNP	p	A121N	0	.	.	361	363	GCC	634	636	GCC	172;170;174	G,A;C,A;C	165,2;163,1;169	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2398	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1574	150.9	1	SNP	p	A121D	0	.	.	361	363	GCC	634	636	GCC	172;170;174	G,A;C,A;C	165,2;163,1;169	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8428	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4733	176.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1048	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1015	102.6	1	SNP	p	V57M	1	.	.	169	171	ATG	467	469	ATG	215;215;215	A;T;G	213;213;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
